SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-249864
Filing Date
2017-08-07
Accepted
2017-08-07 16:06:51
Documents
57
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d421462d10q.htm 10-Q 541210
2 EX-31.1 d421462dex311.htm EX-31.1 9681
3 EX-31.2 d421462dex312.htm EX-31.2 9672
4 EX-32.1 d421462dex321.htm EX-32.1 5578
  Complete submission text file 0001193125-17-249864.txt   2657359

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldx-20170630.xml EX-101.INS 389377
6 XBRL TAXONOMY EXTENSION SCHEMA aldx-20170630.xsd EX-101.SCH 35495
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20170630_cal.xml EX-101.CAL 42079
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20170630_def.xml EX-101.DEF 103612
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20170630_lab.xml EX-101.LAB 283537
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20170630_pre.xml EX-101.PRE 197499
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 171011545
SIC: 2834 Pharmaceutical Preparations